Doctors examine a diabetes patient at the Tue Tinh Hospital in Hanoi. (Photo vutm.edu.vn) Hanoi (VNS/VNA) - The Ministry of Health’s Medical Services Administration(MSA) and the Embassy of Denmark in Vietnam will continue a strategiccollaboration on education on diabetes and other non-communicablediseases for the 2021-2023 period.
Withsupport of Novo Nordisk in Vietnam, the collaboration will focus on capacitybuilding and technical updates for healthcare professionals via virtualcourses. It will strengthen disease awareness education for patients and thepublic on diabetes and other non-communicable diseases via a website ondiabetes at http://daithaoduong.kcb.vn.
Itwill also further facilitate collaboration, best practice and informationsharing to improve quality of care for diabetes and other non-communicablediseases.
“Currently,the whole country and the health sector are fighting against the 4th wave ofthe COVID-19 pandemic. People at high risk during a pandemic are those withunderlying medical conditions such as non-communicable diseases includingdiabetes. Therefore, improving diabetes care is very important in diabetestreatment and COVID-19 pandemic prevention in Vietnam,” said MSA DirectorAssociate Professor Luong Ngoc Khue.
“TheEmbassy of Denmark in Vietnam is glad to see the collaboration on healthbetween Denmark and Vietnam being strengthened, and hopes that this MOU, alongwith the recently signed Strategic Sector Collaboration in Health, will make avaluable contribution to the Vietnamese people,” said Troels Jakobsen,Counsellor at the Embassy of Denmark in Vietnam.
“Weare proud to have this opportunity to continue our support for the bilateralpartnership between the Danish Embassy and Ministry of Health to raise publicawareness of diabetes and improve the quality of care for diabetes at alllevels, especially primary care, through different e-health educationinitiatives such as diabetes journey application and diabetes website,” saidHassan Mahmoud Fahmi, Chief Representative of the Novo Nordisk Office in Vietnam.
Diabetesis one of the most common non-communicable diseases worldwide. Diabetes leadsto many serious complications, and is the leading cause of heart disease,blindness, kidney failure and amputation.
Accordingto the World Diabetes Federation, 463 million adults (age 20-79) or one in 11adults was living with diabetes in 2019 globally. It is estimated that thisnumber will increase to about 700 million people by 2045. However, nearly halfof people living with diabetes (age 20-79) are undiagnosed (46.5 percent) and52.1 percent in the Western Pacific region./.
Withsupport of Novo Nordisk in Vietnam, the collaboration will focus on capacitybuilding and technical updates for healthcare professionals via virtualcourses. It will strengthen disease awareness education for patients and thepublic on diabetes and other non-communicable diseases via a website ondiabetes at http://daithaoduong.kcb.vn.
Itwill also further facilitate collaboration, best practice and informationsharing to improve quality of care for diabetes and other non-communicablediseases.
“Currently,the whole country and the health sector are fighting against the 4th wave ofthe COVID-19 pandemic. People at high risk during a pandemic are those withunderlying medical conditions such as non-communicable diseases includingdiabetes. Therefore, improving diabetes care is very important in diabetestreatment and COVID-19 pandemic prevention in Vietnam,” said MSA DirectorAssociate Professor Luong Ngoc Khue.
“TheEmbassy of Denmark in Vietnam is glad to see the collaboration on healthbetween Denmark and Vietnam being strengthened, and hopes that this MOU, alongwith the recently signed Strategic Sector Collaboration in Health, will make avaluable contribution to the Vietnamese people,” said Troels Jakobsen,Counsellor at the Embassy of Denmark in Vietnam.
“Weare proud to have this opportunity to continue our support for the bilateralpartnership between the Danish Embassy and Ministry of Health to raise publicawareness of diabetes and improve the quality of care for diabetes at alllevels, especially primary care, through different e-health educationinitiatives such as diabetes journey application and diabetes website,” saidHassan Mahmoud Fahmi, Chief Representative of the Novo Nordisk Office in Vietnam.
Diabetesis one of the most common non-communicable diseases worldwide. Diabetes leadsto many serious complications, and is the leading cause of heart disease,blindness, kidney failure and amputation.
Accordingto the World Diabetes Federation, 463 million adults (age 20-79) or one in 11adults was living with diabetes in 2019 globally. It is estimated that thisnumber will increase to about 700 million people by 2045. However, nearly halfof people living with diabetes (age 20-79) are undiagnosed (46.5 percent) and52.1 percent in the Western Pacific region./.
VNA
